B
Bull
Bull · 25%AHG
$2.52
Scenario price
$0.857
-0.108 (-12.57%)At close
Loading chart…
- High
- 0.955
- Open
- 0.910
- VWAP
- 0.89
- Vol
- 15.93K
- Mkt Cap
- 112.36M
- Low
- 0.851
- Amount
- 14.14K
- EV/EBITDA, TTM
- -26.24
Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace.
AI analysis of Akso Health Group (AHG)
sellAkso Health Group is not a good buy right now due to its significant downward momentum and negative financial indicators. The current price is $0.86, which is down 49.60% over the past year. Additionally, the RSI is at a very low 21.16, indicating oversold conditions but also persistent weakness in price action. The forward P/E ratio is 0, suggesting no earnings growth expectations, which is concerning for long-term investment. The main risk is the 5-day change of -7.84%, indicating continued downward pressure on the stock.
Valuation Metrics
The current forward P/E ratio for Akso Health Group (AHG) is 0.00, compared to its 5-year average forward P/E of 0.48.
Alphio AI Price Scenarios for AHG
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Events Timeline
News
3.504-27PRnewswireAkso Health Launches Brain-Computer Interface R&D Program
3.504-27NewsfilterAkso Health Initiates Brain-Computer Interface R&D Program
9.503-10BenzingaU.S. Stocks Rise as NIO Reports Strong Earnings
4.503-10BenzingaU.S. Stocks Mixed in Morning Trading
9.503-03BenzingaIngram Micro Reports Strong Quarterly Earnings, Shares Surge
AHG FAQ — answered by Alphio AI
Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).
Akso Health Group is not a good buy right now due to its significant downward momentum and negative financial indicators. The current price is $0.86, which is down 49.60% over the past year. Additionally, the RSI is at a very low 21.16, indicating oversold conditions but also persistent weakness in price action. The forward P/E ratio is 0, suggesting no earnings growth expectations, which is concerning for long-term investment. The main risk is the 5-day change of -7.84%, indicating continued downward pressure on the stock.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.